# Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer

> clinical trial · VERIFIED · 2026-07-31

Status: ACTIVE_NOT_RECRUITING · Sponsor: Canadian Cancer Trials Group · Condition: Lung Cancer

- Company: Canadian Cancer Trials Group
- Sector: Lung Cancer
- Primary source: https://clinicaltrials.gov/study/NCT04093167

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.